Top news of the week: 28.07.2020.
#COVID19 #news #pharma #pharmiweb #synbio #biotech #pharmaceuticals #CoronaOutbreak #Coronavirus #biotechnology
Career And Jobs
Parker Institute names Connolly as CSO, targets biopharma pacts https://t.co/cDHnyqa4Oi https://t.co/CKjkVrkLH2
OpenParker Institute names Connolly as CSO, targets biopharma pacts
The Parker Institute for Cancer Immunotherapy has named John Connolly, Ph.D., as its chief scientific officer. Connolly joins PICI having previously collaborated with the institute in his ...
Biopharma Update on the Novel Coronavirus: July 22 https://t.co/Yq5G7zAxeU
#biospace #lifesciences #biotechnology #pharmaceuticals
#Coronavirus #COVID19 #CoronaOutbreak #CoronaPandemic
OpenBiopharma Update on the Novel Coronavirus: July 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology
https://t.co/js2JhoxOGH
#news #pharma #pharmiweb
OpenArthex secures €4.25M from Invivo Ventures and Advent France Biotechnology
Valencia and Barcelona, Spain, and Paris, France, July 23, 2020 – Arthex Biotech (ARTHEx), a preclinical stage life sciences company focused on the development of the next generation ...
This panel will highlight several successful paths that scientists can take toward creating a successful #biotech company. https://t.co/rfn0UXlYGo @indbio #synbio
OpenTurning a good scientific idea into a successful biotech startup is a challenging journey.
Learn about NY-based programs supporting biotech startups in this panel featuring the Center for Biotechnology, IndieBio, and BARDA-DRIVe.
British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies
https://t.co/o8YobtOIFY
#news #pharma #pharmiweb
OpenBritish Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies
SV Health Investors closes first fund dedicated to biotechnology at $265mInvestment builds on British Patient Capital’s current commitments to life sciences 20th July 2020 ...
.@GenScript Announces Publication of Clinical Data On New Method for Detecting #COVID19 Neutralizing Antibodies In Nature Biotechnology https://t.co/thTQRdlkiy
OpenGenScript Announces Publication of Clinical Data On New Method for Detecting COVID-19 Neutralizing Antibodies In Nature Biotechnology
GenScript announced that clinical data on a new method for detecting COVID-19 neutralizing antibodies in serum indicates it is safer, faster, easier and more effective than traditional ...
Billionaire Dietmar Hopp steers his secretive Covid-19 biotech player to Nasdaq following major pact with GSK
$CVAC $GSK $LLY $TSLA
https://t.co/zQltPua0m5
OpenBillionaire Dietmar Hopp steers his secretive Covid-19 biotech player to Nasdaq following major pact with GSK
One of the most secretive biotech candidates to lead the development of a new mRNA vaccine to fight Covid-19 just filed their IPO papers for Nasdaq. CureVac, which has been slow to reveal ...
This #Biotech Business Won't Let Cost Get in the Way of a #Covid Cure: Synthetic gene manufacturer @ATUM_bio turned down #venturecapital. That's why it's free to do whatever it takes to fight #Covid19.
https://t.co/l4RxuW62vf
@LeighEBuchanan #synbio
OpenThis Biotech Business Won't Let Cost Get in the Way of a Covid Cure
Synthetic gene manufacturer ATUM turned down venture capital. That's why it's free to do whatever it takes to fight Covid-19.